Gender issues in transplantation

Anesthesia and Analgesia

Volumn 107, Issue 1, 2008, Pages 232-238

  Csete, Marie ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; IMMUNOSUPPRESSIVE AGENT; STEROID; TESTOSTERONE; VITAMIN D; ALLOANTIGEN;

ALLOIMMUNITY; AVASCULAR NECROSIS; BONE MARROW TRANSPLANTATION; DIALYSIS; DISEASE PREDISPOSITION; FEMALE; GENDER; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOGONADISM; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTIVATION; ORGAN DONOR; ORGAN TRANSPLANTATION; OSTEOPOROSIS; OUTCOMES RESEARCH; PREGNANCY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; STEM CELL TRANSPLANTATION; STEROID THERAPY; TREATMENT OUTCOME; IMMUNOLOGY; POSTOPERATIVE COMPLICATION; SEXUAL DEVELOPMENT; TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; FEMALE; HEART TRANSPLANTATION; HUMANS; ISOANTIGENS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE COMPLICATIONS; PREGNANCY; SEX CHARACTERISTICS; STEM CELL TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION;

EID: 49849093888     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318163feaf     Document Type: Article

References (64)

1. Eichwald EJ, Silmser CR, Wheeler N. The genetics of skin grafting. Ann N Y Acad Sci 1957;64:737-40
2. Bohringer D, Spierings E, Enczmann J, Bohringer S, Sundmacher R, Goulmy E, Reinhard T. Matching of the minor histocompat-ibility antigen HLA-A1/H-Y may improve prognosis in corneal transplantation. Transplantation 2006;82:1037-41
3. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991;6:294-8
4. Saverimuttu J, Greenfield T, Rotenko I, Crozier J, Jalaludin B, Harvey M. Implications for urgent transfusion of uncross-matched blood in the emergency department: The prevalence of clinically significant red cell antibodies in different patient groups. Emerg Med 2003;15:239-43
5. Rebibou J-M, Chabod J, Alcalay D, Coussediere M-C, Deteix P, Touchard G, Dupont I, Thevenin C, Chalopin M-M, Tiberghien P. Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation. Transplantation 2002;74:537-40
6. Guleria I, Sayegh MH. Maternal acceptance of the fetus: true human tolerance. J Immunol 2007;178:3345-51
7. Sanfey H. Gender-specific issues in liver and kidney failure and transplantation: a review. J Womens Health 2005;14:617-26
8. Carr DB, Larson Am, Schmucker BD, Brateng DA, Carithers RL Jr, Easterling TR. Maternal hemodynammics and pregnancy outcome in women with prior orthotopic liver transplantation. Liver Transpl 2000;6:213-21
9. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1996-2005. Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2006
10. Lima DX, Petroianu A, Hauter HL. Quality of life and surgical complications of kidney donors in the late post-operative period in Brazil. Nephrol Dial Transpl 2006;21:3238-42
11. Zimmerman D, Donnelly S, Miller J, Stewart D, Albert SE. Gender disparity in living renal transplant donation. Am J Kidney Dis 2000;36:534-40
12. Kayler LK, Meier-Kriesche HU, Punch JD, Campbell DA Jr, Leichtman AB, Magee JC, Rudich SM, Arenas JD, Merion RM. Gender imbalance in living donor renal transplantation. Transplantation 2002;73:248-52
13. Biller-Adorno N. Gender imbalance in living organ donation. Med Health Care Philos 2002;5:199-204
14. A Report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation 2005;79:S53-66
15. Soucie JM, Neylan JF, McClellan W. Race and sex differences in the identification of candidates for renal transplantation. Am J Kidney Dis 1993;22:414-9
16. Newman H, Reems JA, Rigley TH, Bravo D, Strong DM. Donor age and gender are the strongest predictors of marrow recovery from cadaveric vertebral bodies. Cell Transplant 2003;12:83-90
17. Kim SC, Han DJ, Kang CH, We YM, Back JH, Kim YH, Kim JH, Lim DG. Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc 2005;37:3402-3
18. Young LE, Little MA. Women and heart transplantation: an issue of gender equity? Health Care Women Int 2004;25: 436-53
19. Aaronson KD, Sanford Schwartz J, Goin JE, Mancini DM. Sex differences in patient acceptance of cardiac transplant candidacy. Circulation 1995;91:2753-61
20. Cochran RP, Panos A. Coronary artery by-pass surgery. In: Douglas PS, ed. Cardiovascular health and disease in women. 2nd ed. Toronto: W. B. Saunders; 2002:372-82
21. Ahn HJ, Kim HJ, Kim YS, Kim MS, Huh KH, Kim JH, Lee JH, Jeon KO, Sim SI. Risk factors for changes in bone mineral density and the effect of antiosteoporosis management after renal transplantation. Transplant Proc 2006;38:2074-6
22. Vleggaar FP, van Buuren HR, Wolfhagen FHJ, Schalm SW, Pols HAP. Prevention and treatment of osteoporosis in primary biliary cirrhosis. Eur J Gastroent Hepatol 1999;11:617-22
23. Stempfle H-U, Werner C, Echtler S, Wehr U, Rambeck WA, Siebert U, Uderfuhr P, Angermann CE, Theisen K, Gartner R. Prevention of ostoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with cal-citriol. Transplantation 1999;68:523-30
24. Schulte CM, Beelen DW. Avascular osteonecrosis after alloge-neic hematopoietic stem-cell transplantation: diagnosis and gender matter. Transplantation 2004;78:1055-63
25. Reyes D, Kew SQ, Kimmel PL. Gender differences in hypertension and kidney disease. Med Clin N Am 2005;89:613-30
26. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-85
27. Dubey RK, Gillespie DG, Keller PJ, Imthurn B, Zacharia LC, Jackson EK. Role of methoxyesstradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells. Hypertension 2002;39:418-24
28. Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK. Incidence and risk factors of atherosclerotic cardiovascular accidents in pre-dialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997;12:2597-602
29. Oien CM, Reisaeter AV, Os I, Jardine A, Fellstrom B, Holdaas H. Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study. Clin Transplant 2006;20:374-82
30. Ben Hamida F, Ben Abdallah T, Abdelmoula M, Mejri H, Goucha R, Abderrahim E, el Younsi F, Hedri H, Ben Moussa F, Kheder MA, Ben Maiz H. Impact of donor/recipient gender, age, and HLA matching on graft survival following living-related renal transplantation. Transplant Proc 1999;31: 3338-9
31. Kouli F, Morrell CH, Ratner LE, Kraus ES. Impact of donor/recipient traits independent of rejection on long-term renal function. Am J Kidney Dis 2001;37:356-65
32. Muller V, Szabo A, Viklicky O, Gaul I, Portl S, Philipp T, Heemann UW. Sex hormones and gender related differences: their influence on chronic renal allograft rejection. Kidney Int 1999;55:2011-20
33. Zeier M, Dohler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol 2002;13:2570-6
34. Smith MC, Ward MK, Sturgiss SN, Milne JE, Davison JM. Sex and the pregnant kidney: does renal allograft gender influence gestational renal adaptation in renal transplant recipients? Transplant Proc 2004;36:2639-42
35. Dharnidharka VR, Agodoa LY, Abbott KC. Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients-an analysis of USRDS data. Am J Transplant 2007; 7:653-6
36. Smith JM, Rudser K, Gillen D, Kestenbaum B, Seliger S, Weiss N, McDonald RA, Davis CL, Stehmen-Breen. Risk of lymphoma after renal transplantation varies with time: an analysis of the United States Renal Data System. Transplantation 2006;81: 175-80
37. Burden of liver disease in the United States: summary of a workshop (www.hcvadvocate.org/hepatitis/hepC/Burden.html) Epidemiology and the impact of liver disease in the United States, May 19, 2001, Atlanta, GA
38. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62
39. Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M, El-Kafrawy S, Esmat G, Hamid MA, Mohamed MK, Fontanet A. Higher clearance of hepatitis C virus infection in females compared to males. Gut 2006;55:1183-7
40. Yamakawa Y, Sata M, Suzuki H, Noguchi S, Tanikawa K. Higher elimination of hepatitis C virus among women. J Viral Hepat 1996;6:317-21
41. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006;40:S5-10
42. Balistreri W, Grand R, Suchy F, Ryckman F, Perlmutter D, Sokol R. Biliary atresia: summary of a symposium. Hepatology 1996;23: 1682-92
43. Pyrsopoulos NT, Reddy KR. Primary biliary cirrhosis. WebMD. Available at: http://www.emedicine.com/med/topic223.html
44. Kohan AI, Findor JA, Igartua EB, Villaravid N. Intensive plasmapheresis as an alternate therapy for intractable pruritis of primary biliary cirrhosis. Transfus Sci 1991;12: 197-200
45. Jones EA, Neuberger J, Bergasa NV. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM 2002;95:547-52
46. Zylica Z, Stork N, Krajnik M. Severe pruritis of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report. J Pain Symptom Management 2005;20:100 -3
47. Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Surgical outcome in patients with primary sclerosing cholangi-tis undergoing ileal pouch-anal anastomosis: a case-control study. Surgery 2005;138:631-7
48. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Int Med 1997;127:105-10
49. Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS Liver Transplant Registry. Clin Transpl 2004;18:315-29
50. Chan EY, Larson AM, Gernsheimer TB, Kowdley KV, Carithers RL Jr, Reyes JD, Perkins JD. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients. Liver Transpl 2007;13:516-22
51. Brooks BK, Levy MF, Jennings LW, Abbasoglu O, Vodapally M, Golstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 1996;62:1784-7
52. Rustgi VK, Marino G, Halpern MT, Johnson LB, Umana WO, Tolleris C. Role of gender and race mismatch and graft failure in patients undergoing liver transplantation. Liver Transplant 2002;8:514-6
53. Gupta P, Hart J, Cronin D, Kelly S, Millis JM, Brady L. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001;72:1098-102
54. Mehta P, Pollock BH, Nugent M, Horowitz M, Wingard JR. Access to stem cell transplantation: do women fare as well as men? Am J Hematol 2003;72:99-102
55. Pond GR, Lipton JH, Messner HA. Long-term survival after blood and marrow transplantation: comparison with an age-and gender-matched normative population. Biol Blood Marrow Transplant 2006;12:422-9
56. Gustafsson Jernberg A, Remberger M, Ringden O, Winiarski J. Risk factors in pediatric stem cell transplantation for leukemia. Pediatr Transplant 2004;8:464-74
57. Gahrton G, Iacobelli S, Apperley J, Bandini G, Bjorkstrand B, Blade J, Boiron JM, Cavo M, Cornelissen J, Corradini P, Kroger N, Ljungman P, Michallet M, Russell NH, Samson D, Schattenberg A, Sirohi B, Verdonck LF, Volin L, Zander A, Niederwieser D. The impact of donor gender on outcome of allogeneic hemato-poietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant 2005;35:609-17
58. Fuge R, Bird JM, Fraser A, Hart D, Hunt L, Cornish JM, Goulden N, Oakhill A, Pamphion DH, Steward CG, Marks DI. The clinical features, risk factors and outcome of thrombotic throm-bocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 2001;113:58-64
59. Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, Morreale G, Lanino E, Annaloro C, Volpe AD, Alessandrino P, Longoni D, Locatelli F, Sangalli H, Rovelli A. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 2006; 82:638-44
60. Partridge T. Myoblast transplantation. Neuromusc Disord 2002;12(suppl 1):S3-6
61. Deasy BM, Lu A, Tebbets JC, Feduska JM, Schugar RC, Pollett JB, Sun B, Urish KL, Gharaibeh BM, Cao B, Rubin RT, Huard J. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol 2006;177:73-86
62. Crisostomo PR, Wang M, Herring CM, Morrell ED, Seshadri P, Meldrum KK, Meldrum DR. Sex dimorphisms in activated mesenchymal stem cell function. Shock 2006;26:571-4
63. Hoetzer GL, MacEneaney OJ, Irmiger HM, Deith R, Van Guilder GP, Stauffer BL, DeSouza CA. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 2007;99:46-8
64. Bianchi DW, Fish NM. Fetomaternal cell trafficking and the stem cell debate. Gender matters. JAMA 2007;297:1489-91